SCHEMBL17385

SCHEMBL17385

CC#C[C@H]1CN(S(=O)(=O)c2cccs2)CCN1c1ncc(C(C)(O)C(F)(F)F)cn1

nearest known ligand 0.59

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCKR Q14397 15/20 0.59
GCK P35557 6/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12079814 1.00 GCKR (0.59) GCKRGCK
SCHEMBL12079190 1.00 GCKR (0.59) GCKRGCK
SCHEMBL12080030 1.00 GCKR (0.59) GCKRGCK
SCHEMBL16560 1.00 GCKR (0.59) GCKRGCK
SCHEMBL17301 1.00 GCKR (0.59) GCKRGCK
SCHEMBL19493 1.00 GCKR (0.59) GCKRGCK
SCHEMBL17247 0.93 GCKR (0.69) GCKRGCK
SCHEMBL12077896 0.93 GCKR (0.69) GCKRGCK
SCHEMBL18185 0.93 GCKR (0.69) GCKRGCK
SCHEMBL12090041 0.92 GCKR (0.55) GCKRGCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed